Sphingosine‐1‐phosphate induces COX‐2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells

Abstract

Sphingosine 1-phosphate (S1P) has been shown to regulate smooth muscle cell proliferation, migration, and vascular maturation. S1P increases the expression of several proteins including COX-2 in vascular smooth muscle cells (VSMCs) and contributes to arteriosclerosis. However, the mechanisms regulating COX-2 expression by S1P in VSMCs remain unclear. Western blotting and RT-PCR analyses showed that S1P induced the expression of COX-2 mRNA and protein in a time- and concentration-dependent manner, which was attenuated by inhibitors of MEK1/2 (U0126) and PI3K (wortmannin), and transfection with dominant negative mutants of p42/p44 mitogen-activated protein kinases (ERK2) or Akt. These results suggested that both p42/p44 MAPK and PI3K/Akt pathways participated in COX-2 expression induced by S1P in VSMCs. In accordance with these findings, S1P stimulated phosphorylation of p42/p44 MAPK and Akt, which was attenuated by U0126, LY294002, or wortmannin, respectively. Furthermore, this up-regulation of COX-2 mRNA and protein was blocked by a selective NF-kappaB inhibitor helenalin. Consistently, S1P-stimulated translocation of NF-kappaB into the nucleus was revealed by immnofluorescence staining. Moreover, S1P-stimulated activation of NF-kappaB promoter activity was blocked by phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 and helenalin, but not by U0126, suggesting that involvement of PI3K/Akt in the activation of NF-kappaB. COX-2 promoter assay showed that S1P induced COX-2 promoter activity mediated through p42/p44 MAPK, PI3K/Akt, and NF-kappaB. These results suggested that in VSMCs, activation of p42/p44 MAPK, Akt and NF-kappaB pathways was essential for S1P-induced COX-2 gene expression. Understanding the mechanisms involved in S1P-induced COX-2 expression on VSMCs may provide potential therapeutic targets in the treatment of arteriosclerosis.

Enhanced Phosphoinositide 3-Kinase δ Activity Is a Frequent Event in Systemic Lupus Erythematosus That Confers Resistance to Activation-Induced T Cell Death

“…We concentrated on apoptosis, as a large percentage of patients showed reduced apoptosis (AICD), and PI3K activation triggers cell survival (18). Other defects have been reported: Treg involvement in SLE (3,37), anergy defects (47,48), and the contribution of Th-17 cells (49). Despite potential involvement of additional tolerance mechanisms in SLE, our findings show that AICD is defective in this disease and corrected by p110d inhibition.…”

Sphingosine-1-Phosphate-Induced Inflammation Involves Receptor Tyrosine Kinase Transactivation in Vascular Cells

“…Second messengers and molecular pathways linking RTKs to MAPKs involve tyrosine kinases, such as c-Src, and Pyk2; transcription factors, such as hypoxia-inducible factor 1; and generation of reactive oxygen species. 13,39,40 Although MAPK phosphorylation was completely blocked by growth factor receptor inhibitors in WKY cells, effects were only partial in SHRSP cells, suggesting the importance of pathways other than through EGFRs and PDGFRs in this response.…”

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors

“…Because recent studies implicate S1P in regulation of COX-2 expression in A549 human lung cancer cells, 41 fibroblasts, 37,38 and smooth muscle cells, 39 we examined whether S1P can up-regulate COX-2 expression in mast cells. In agreement with previous results, 42 Ag triggering increased COX-2 expression in RBL-2H3 cells, yet S1P failed to increase COX-2 even after 5 hours (Figure BLOOD, 1 FEBRUARY 2007 ⅐ VOLUME 109, NUMBER 3 For personal use only.…”